Background: MSCs are a promising therapeutic resource. Paracrine effects and the induction of differentiation patterns are thought to represent the two primary mechanisms underlying the therapeutic effects of mesenchymal stem cell (MSC) transplantation in vivo. However, it is unclear which mechanism is involved in the therapeutic effects of human umbilical cordderived MSC (hUC-MSC) transplantation. Methods and Results: analysis, hUC-MSCs exhibited the morphological characteristics and surface markers of MSCs. Following directed neural induction, these cells displayed a neuron-like morphology and expressed high levels of neural markers. All types of hUC-MSCs, including differentiated and redifferentiated cells, promoted learning and memory function recovery in hypoxic-ischemic brain damaged (HIBD) rats. The hUC-MSCs secreted IL-8, which enhanced angiogenesis in the hippocampus via the JNK pathway. However, the differentiated and redifferentiated MSCs. Conclusion: hUC-MSCs display the biological properties and neural differentiation potential of MSCs and provide therapeutic advantages by secreting IL-8, which participates in angiogenesis in the rat HIBD model. These data suggest that hUC-MSC transplantation improves the recovery of neuronal function via an IL-8-mediated secretion mechanism, whereas differentiation pattern induction was limited.
Introduction
Along with improvements in medical technology and therapeutic ability, the morbidity of hypoxic-ischemic brain damage (HIBD) has increased each year [1] , demonstrating the need for improved treatment methods. Studies by other groups [2] [3] [4] and our research group [5, 6] have consistently demonstrated that mesenchymal stem cells (MSCs) transplanted from bone marrow represent a useful therapeutic strategy for treating neurological disorders. However, in many studies, the sources of MSCs have been limited to animals, with a long path to human clinical applications. Human umbilical cords are an attractive source of MSCs, as they display many advantages compared to other stem cell types, such as embryonic stem cells, in terms of reduced tumourigenicity, immunogenicity, and ethical issues. They also exhibit increased proliferation compared to bone marrow derived-MSCs and are considered more valuable for transplantation in stem cell therapy and research studies [7, 8] . However, to the best of our knowledge, it is unclear whether hUC-MSCs exhibit better biological characteristics and a higher potential for neural differentiation than other MSCs.
According to the accumulated evidence, the two primary mechanisms considered to underlie the therapeutic effects of MSCs in neurological disorders include the facilitation of the paracrine secretion of cytokines and the induction of neural differentiation patterns. Some studies have demonstrated that MSCs directly release or promote the release of various cytokines, including chemokines and growth and trophic factors, from the injured and promote neurogenesis and angiogenesis in the injured microenvironment [11, 12] , and improve neurological function in the brains of injured animals. However, some studies have supported a different perspective regarding the potency of MSCs to induce neuronal differentiation. It has been proposed that implanted MSCs can differentiate into mature neural differentiation in vivo [13, 14] . Therefore, some research groups have attempted to improve this differentiation rate and thus increase the therapeutic potential of MSCs in various animal models by inducing these cells in vitro [15] [16] [17] . Some studies have suggested that hUC-MSCs improve neurological disease by either enhancing a paracrine effect or inducing differentiation patterns [18, 19] . However, to the best of our knowledge, very few reports have addressed which mechanism participates in the therapeutic effects of these cells during HIBD. differentiation and redifferentiation (neural differentiation for the second time) potential of hUC-MSCs in vitro. We then transplanted undifferentiated, differentiated and redifferentiated hUC-MSCs into HIBD rats to identify any therapeutic advantages in vivo. Finally, we investigated a possible mechanism by which hUC-MSC-secreted IL-8 might help promote the recovery of learning and spatial memory capabilities in HIBD rats. 
Materials and Methods

Culture and expansion of hUC-MSCs
Induction of neuronal differentiation and redifferentiation
5 undifferentiated hUC-MSCs were induced using MNM for 24 hours to achieve neuronal differentiation 24 hours following neuronal differentiation. Cells were then transferred to MNM for another 24 hours to Image J software. Three independent experiments were performed and evaluated.
RNA extraction and analysis
-actin. The primer sequences are listed in Table 1 .
Western blot
of different concentrations (Beyotime, Shanghai, China) were prepared, and proteins of interest were electrophoretically separated according to their molecular weight. The anti-NSE, anti-MAP2, anti--tubulin-III and anti-IL-8 primary antibodies were purchased from Abcam (Cambridge, MA, USA). The antiantibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The proteins of interest 
Enzyme-linked immunosorbent assay (ELISA)
USA), and the TIMP-1 and CCL2 commercial ELISA kits were purchased from 4A Biotech Co., Ltd. The experimental procedure was performed in accordance with the corresponding reagent kit protocol. The
Establishment of siIL-8-hUC-MSC cell line
8-infected hUC-MSCs. A single siIL-8-infected hUC-MSC was seeded into a 96-well plate to obtain stable (gccaaggagtgctaaagaact) for hIL-8.
Microarray analysis
. All
Cluster version 2.11 software. Affymetrix® NetAffx™Analysis Center software was used for gene ontology two-fold, and the differentially expressed genes were selected for further analyses. The microarray data was
Animal studies
All animal experiments were approved by the Ethical Committee of Chongqing Medical University. Sprague Dawley (SD) rats were purchased from the Experimental Animal Center of Chongqing Medical laboratory. The animal housing rooms were maintained at a constant temperature (25 light-dark cycle, and the animals were provided with access to food and water ad libitum.
Rat HIBD model and cell transplantation
5 cells suspended in 5 L of sterile PBS were transplanted into the HIBD rats (n=76, 12 days old) via intracerebroventricular injection. The injection site was located 1.2 mm posterior to the bregma, 1.4 mm to the left of the lambdoid suture and at a needle depth of 3.6 mm. The injection rate was 1 was used to control the injection, which lasted a total of 5 min. The needle remained in the lateral ventricle for 2 min. The HIBD control group (n=27) was injected with the same volume of sterile PBS. The sham group (n=18) received the sham surgery without hypoxia-ischemia or cell transplantation. group(n=3) were collected. For haematoxylin-eosin (HE) staining, 4-m continuous coronary slices on glass slides were stained with HE, and the pathology and morphology of the cells were analysed using a applied to dehydrate the tissue sections. These sections were immunostained with monoclonal mouse Cellular Physiology and Biochemistry
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Invitrogen or Proteintech (Wuhan, China). Images were captured via laser scanning confocal microscopy (Nikon).
Morris water maze test
cell transplantation, the rats from the sham group (n=9, 6 weeks old), HIBD group (n=18), hUC-MSC group time (escape latency) and distance (path length) required to locate the platform were recorded. During the
Object-in-place task
This behavioural test was performed in a 1 m 2 open-topped box constructed of black Plexiglas. During the pretraining phase, the animals (n=42, 6 weeks old) were placed in the empty box to adapt to the toys were placed at the four corners of the box, and the animals were allowed to explore the novel objects for 5 min. During the delay period (5 min), all objects were cleaned with alcohol to remove olfactory cues and any sawdust, and two adjacent toys were exchanged (excluding the two diagonal toys). During the test phase (3 min), the animals were placed in the box again, and the time spent exploring the four toys was recorded. In the subsequent analysis, the ratio of the time spent exploring the two novel objects (changed position) to the time spent exploring the two familiar objects (unchanged position) was compared.
In vivo electrophysiology
All chemicals used for the electrophysiology experiments were purchased from Sigma. The rats hippocampal slices were transferred to a chamber placed on the stage of an upright microscope (Nikon . The recording and stimulating electrodes were placed in the CA1 area of the hippocampal slice. Extracellular before tetanic stimulation. To induce LTP, high frequency stimulation (HFS) was applied, and the effects
Statistical analysis
Results demonstrated no apparent morphological differences compared to the cells at passage 2 (Fig. 1A middle and right) . To determine the karyotypic stability of increasing cell passages, and 15. As shown in Fig. 1B , chromosomal aberration of the hUC-MSCs was not observed during 15 generations, suggesting that these hUC-MSCs maintained a normal chromosomal structure for at least 15 passages. Subsequently, cell-surface antigen expression was Cellular Physiology and Biochemistry
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-tubulin-III, were examined in the three induced groups. Fig. 2B , 2D and 2F reveal that the -tubulin-III were gradually increased following the induction of differentiation and redifferentiation. In response to the redifferentiation successfully induced to differentiate into neuron-like cells expressing high levels of neural markers via an in vitro redifferentiation method.
Therapeutic effect of hUC-MSC transplantation in the HIBD rat model
experiments consisting of brain histopathological evaluation, rat behavioural tests and electrophysiological examination of brain slices were performed in vivo. Based on HE staining, the periventricular brain tissue displayed uneven, diffuse staining and nuclear condensation (Fig. 3A middle) , and the cell morphology in the HIBD pups was altered compared to the sham rats. In contrast, hUC-MSC transplantation partially alleviated these changes (Fig. 3A right) . To analyse the spatial learning and memory ability of the HIBD rats, the Morris water maze test was performed four weeks following hUC-MSC transplantation.
was detected (p transplantation did not affect the movement or visual ability of the rats (Fig. 3B-3C ). During the hidden platform training (Day 2-5), all of the groups demonstrated gradual decreases in the escape latency. The HIBD group exhibited a longer escape latency than the sham group of the rats for objects using an object-in-place task. The data in Fig. 3F show that the HIBD rats spent less time investigating the two objects at the new location than the sham rats ( To examine whether hUC-MSC transplantation facilitates hippocampal synaptic plasticity, we recorded fEPSPs in the hippocampal CA1 region of brain slices. The basal level the three groups. The above results suggest that hUC-MSC transplantation improved spatial learning and memory function and enhanced hippocampal synaptic plasticity in HIBD rats.
Therapeutic potential of neuronal differentiation and redifferentiation of hUC-MSCs in vivo
To evaluate the effects of the differentiated and redifferentiated cells on biological function in vivo, we transplanted differentiated or redifferentiated hUC-MSCs into the HIBD path length during the Day 1 test was detected between the three groups (P the escape latency of all three groups gradually decreased, demonstrating that the rats in 
hUC-MSCs in vitro
To explain the high in vitro neural potential and the lack of therapeutic advantages in vivo
Dif groups displayed similar gene expression patterns, which were very different from that of the undifferentiated hUC-MSCs (Fig. 5A -5B). Then, we screened the consistently altered genes in the three groups (consistently increased or decreased) and selected 483 genes in Fig. 5C , following neural differentiation and redifferentiation, the Dif group exhibited undifferentiated hUC-MSCs group. Furthermore, these differentially expressed genes were analysed via gene ontology and biological function analyses. The histogram in Fig. 5D shows the top 15 biological functions of the differentially expressed genes, which included signal transduction, development, negative regulation of cell proliferation, cell cycle, and nervous many possible signalling pathways, the cytokine-cytokine receptor interaction pathway function in HIBD rats following hUC-MSC transplantation. Therefore, to explore the molecular mechanism underlying the therapeutic effect of hUC-MSCs, the expression levels data. We found that the hUC-MSCs expressed high levels of many cytokine genes, such as TIMP-1, IL-8, and CXCL1 (Fig. 6A) . Furthermore, ELISA was applied to verify the gene chip results. As shown in Fig. 6B , IL-8 was the cytokine that showed the highest level of secretion change in the IL-8 protein level in rat brain tissue and, surprisingly, found that both the restoration of learning and memory function in the HIBD rats. IL-8 is an important factor that promotes angiogenesis and participates in many physiological processes. Angiogenesis was evaluated to elucidate the role of IL-8 in vivo.
HIBD
revealed that the number of endothelial cells displaying CD31 and BrdU double-labelling (Fig. 7E) . These data indicate that IL-8 secreted by hUC-MSCs may regulates angiogenesis in
siIL-8-hUC-MSC transplantation inhibits angiogenesis in the hippocampus of HIBD rats via the JNK pathway
To verify the hypothesis that IL-8 secreted by hUC-MSCs regulates angiogenesis in the following transplantation, the levels of hIL-8 secretion and IL-8 protein expression in rat Student's t the siIL-8-hUC-MSC group exhibited a longer escape latency (Fig. 8H lower left) , although Student's t test) (Fig. 8H lower right) . The above results further support our hypothesis that IL-8 secreted by hUC-MSCs regulates angiogenesis in the hippocampus of HIBD rats via the present study exhibited the morphological characteristics and immunophenotype of hMSCs, which was consistent with other studies [23, 24] . Furthermore, the hUC-MSCs exhibited excellent proliferative capacity and chromosomal stability until passage 15, indicating that they are safe for clinical application. The multi-lineage differentiation potential of these was
MSCs display the ability to cross the germinal layer to differentiate into neuron-like cells and produce greater functional results than undifferentiated stem cells, suggesting that MSCs represent excellent transplantation cells for cell-based therapy and tissue engineering [26, 27] . Additionally, our previous studies have demonstrated that differentiated and 28]. Whether hUC-MSCs, a special type of MSC, display neuronal differentiation potency was unclear. To address this issue, hUC-MSCs were subjected to a differentiation induction programme. Surprisingly, the differentiated cells did not exhibit a neuron-like morphology, although their neural marker levels were higher than those of the undifferentiated hUCon the hUC-MSCs. Interestingly, the redifferentiated cells exhibited dramatic morphological changes and expressed much higher levels of neural markers than the differentiated hUCMSCs, suggesting that the hUC-MSCs used in the present study display in vitro neuronal differentiation potency. Moreover, because the differentiated hUC-MSCs maintained a similar morphology to the undifferentiated hUC-MSCs, hUC-MSCs from humans may display more strictly conservative properties than MSCs derived from rats. The initial differentiation was redifferentiation induced morphological changes and increased neural marker expression. Further studies should be conducted to elucidate the precise mechanism underlying these changes.
To evaluate the therapeutic effects of the three states of hUC-MSCs, differentiated, redifferentiated or undifferentiated hUC-MSCs were transplanted into HIBD rats. Because previous studies have reported that ischemia-related gene expression occurs in a timeserve as the most appropriate method for treating nervous system diseases because this method results in the most extensive grafting of the implanted cells to the injured tissue.
that the hUC-MSCs in all the three states promoted the recovery of neural function in HIBD rats, indicating that hUC-MSC transplantation showed an advantage in HIBD rats, which was consistent with a previous study [18] . However, the results also showed that therapeutic advantages than the undifferentiated hUC-MSCs. Some studies have shown that cells (ASCs) were effective in promoting nerve regeneration [32] , and the undifferentiated that inducing differentiation and redifferentiation neural patterns may not be a necessary component of the treatment process.
To explain the high in vitro neural potential and the lack of therapeutic advantages of hUC-MSCs in vivo Based on analysis of the chip results, the induction of differentiation and redifferentiation in hUC-MSCs was clearly a gradual process that produced distinct gene expression patterns. Importantly, the cytokine-cytokine receptor interaction pathway primarily participated in this process. 
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The regulation of the injury microenvironment by secreted cytokines and the induction of differentiation are the two primary mechanisms thought to contribute to the therapeutic effects of MSCs [34, 35] . As mentioned previously, the differentiated and redifferentiated cells did not further restore biological functions compared to undifferentiated hUC-MSCs production in hUC-MSCs merited further investigation. We found that IL-8 was the most abundantly secreted cytokine by hUC-MSCs in vitro. Surprisingly, the levels of both hILtransplanted brain tissue, suggesting that IL-8 secretion by hUC-MSCs may improve the restoration of learning and memory function in HIBD rats. IL-8 is an important angiogenic factor [36] that enhances endothelial cell proliferation and survival and that regulates angiogenesis [37, 38] . Several independent reports have demonstrated that IL-8 stimulates protein expression was clearly increased in the hUC-MSC-treated group. These data indicate that the IL-8 secreted by hUC-MSCs may regulates angiogenesis in the hippocampus of HIBD To validate the effects of IL-8 from hUC-MSCs on hippocampal angiogenesis via the into the HIBD rats, we found that levels of both hIL-8 secretion and IL-8 protein expression decreased by siIL-8-hUC-MSC transplantation, thereby suggesting that the decrease in hUChUC-MSC transplantation improves the recovery of learning and memory functions via IL-8 secretion.
Conclusion
In summary, we demonstrated that hUC-MSCs exhibit the biological characteristics of stem cells and display neural directional differentiation potential. hUC-MSC transplantation improved the recovery of learning and memory functions via IL-8 secretion, which enhanced angiogenesis in the hippocampus of HIBD rats, but this treatment did not induce clinical application of hUC-MSCs to hypoxic-ischemic disorders.
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